By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
Jian'an Wang School of Medicine Zhejiang University Hangzhou China
Dr. Wang is the chief of heart center, and the President of the Second Affiliated Hospital, Zhejiang University School of Medicine. He is currently the chairman of Zhejiang Provincial Cardiology Association, vice-chairman of Chinese Society of Cardiology and the deputy Editor-in-Chief of Chinese Journal of Cardiology. He is full of enthusiasm in medical practice, research and education to promote health management in the population. He advocates evidence-based medicine, and is experienced in interventional cardiology, covering from invasive imaging, coronary catheterization, transcatheter aortic valve replacement (TAVR) and percutaneous mitral valve clip. He is one of the pioneers in China for cell therapy of cardiovascular diseases and won National Science & Technology Progress Award (second class) for his innovative work in cardiac repair post myocardial infarction.